- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | BMO Capital Lowers its Price Target on McGraw Hill, Inc. (MH) to $19 and Maintains an Outperform Rating | ||
| Di | Goldman Sachs Lowers its Price Target on H&R Block, Inc. (HRB) to $32 and Maintains a Sell Rating | ||
| Di | BofA Lowers its Price Target on Etsy, Inc. (ETSY) to $63 and Maintains a Neutral Rating | ||
| Di | Stephens Upgrades Boot Barn Holdings, Inc. (BOOT) to Overweight from Equal Weight and Raises its Price Target to $237 | ||
| Mo | 12 Dividend Stocks With High Insider Buying | ||
| Mo | 10 AI Stocks to Watch: Broadcom, AMD, and More | ||
| Mo | Hedge Fund and Insider Trading News: George Soros, Bill Ackman, Warren Buffett, Steve Cohen, Elliott Management, L1 Capital, Citadel Investment Group, Mattel Inc (MAT), and More | ||
| Mo | Arcellx (ACLX) Shares Encouraging Data on Latest Laboratory Study | ||
| Mo | Here is Why Apogee Therapeutics (APGE) Appears Attractive | ||
| Mo | Atacicept's Potential Approval Drives Favorable Views on Vera Therapeutics (VERA) | ||
| Mo | Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026 | ||
| Mo | Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX) | ||
| Mo | Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA) | ||
| Mo | What Makes BioMarin (BMRN) so Attractive | ||
| Mo | Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough | ||
| Mo | FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) | ||
| Mo | Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance | ||
| Mo | FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT) | ||
| Mo | Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE) | ||
| Mo | Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program | ||
| Mo | Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry | ||
| Mo | Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX) | ||
| Mo | Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating | ||
| Mo | UBS Still Neutral on East West Bank (EWBC) | ||
| Mo | UBS Retained Buy Recommendation on SouthState Bank (SSB) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.